nodes	percent_of_prediction	percent_of_DWPC	metapath
Micafungin—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—esophageal cancer	0.0229	0.151	CbGpPWpGaD
Micafungin—ARSA—digestive system—esophageal cancer	0.0161	0.204	CbGeAlD
Micafungin—ARSA—lung—esophageal cancer	0.0135	0.171	CbGeAlD
Micafungin—ARSA—lymph node—esophageal cancer	0.00921	0.117	CbGeAlD
Micafungin—COMT—Estrogen metabolism—CYP1B1—esophageal cancer	0.00906	0.0598	CbGpPWpGaD
Micafungin—COMT—bronchus—esophageal cancer	0.00847	0.107	CbGeAlD
Micafungin—COMT—smooth muscle tissue—esophageal cancer	0.00828	0.105	CbGeAlD
Micafungin—COMT—trachea—esophageal cancer	0.0076	0.0964	CbGeAlD
Micafungin—COMT—digestive system—esophageal cancer	0.00654	0.0829	CbGeAlD
Micafungin—COMT—lung—esophageal cancer	0.00546	0.0692	CbGeAlD
Micafungin—Hepatocellular injury—Cisplatin—esophageal cancer	0.00527	0.00688	CcSEcCtD
Micafungin—Hiccups—Cisplatin—esophageal cancer	0.00527	0.00688	CcSEcCtD
Micafungin—Mucosal inflammation—Methotrexate—esophageal cancer	0.00522	0.00682	CcSEcCtD
Micafungin—Hyperkalaemia—Cisplatin—esophageal cancer	0.00518	0.00676	CcSEcCtD
Micafungin—Body temperature increased—Carboplatin—esophageal cancer	0.00507	0.00661	CcSEcCtD
Micafungin—Skin exfoliation—Cisplatin—esophageal cancer	0.00503	0.00656	CcSEcCtD
Micafungin—Fungal infection—Capecitabine—esophageal cancer	0.00503	0.00656	CcSEcCtD
Micafungin—Fluid retention—Cisplatin—esophageal cancer	0.005	0.00653	CcSEcCtD
Micafungin—Coagulopathy—Capecitabine—esophageal cancer	0.00499	0.00651	CcSEcCtD
Micafungin—Febrile neutropenia—Methotrexate—esophageal cancer	0.00481	0.00627	CcSEcCtD
Micafungin—Injection site pain—Capecitabine—esophageal cancer	0.00476	0.00621	CcSEcCtD
Micafungin—Rigors—Capecitabine—esophageal cancer	0.00476	0.00621	CcSEcCtD
Micafungin—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00475	0.0062	CcSEcCtD
Micafungin—ARSA—Post-translational protein modification—ST6GAL1—esophageal cancer	0.00457	0.0302	CbGpPWpGaD
Micafungin—Encephalopathy—Methotrexate—esophageal cancer	0.0045	0.00588	CcSEcCtD
Micafungin—Phlebitis—Cisplatin—esophageal cancer	0.00444	0.00579	CcSEcCtD
Micafungin—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00427	0.00557	CcSEcCtD
Micafungin—Hypocalcaemia—Capecitabine—esophageal cancer	0.00424	0.00554	CcSEcCtD
Micafungin—Liver disorder—Methotrexate—esophageal cancer	0.00424	0.00554	CcSEcCtD
Micafungin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.00424	0.00553	CcSEcCtD
Micafungin—Renal failure acute—Cisplatin—esophageal cancer	0.00414	0.00541	CcSEcCtD
Micafungin—COMT—Phase II conjugation—GSTO1—esophageal cancer	0.00412	0.0272	CbGpPWpGaD
Micafungin—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00411	0.00536	CcSEcCtD
Micafungin—Cyanosis—Methotrexate—esophageal cancer	0.00408	0.00533	CcSEcCtD
Micafungin—Inflammation—Capecitabine—esophageal cancer	0.004	0.00523	CcSEcCtD
Micafungin—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00395	0.00516	CcSEcCtD
Micafungin—Hiccups—Capecitabine—esophageal cancer	0.00388	0.00507	CcSEcCtD
Micafungin—Pulmonary embolism—Capecitabine—esophageal cancer	0.00388	0.00507	CcSEcCtD
Micafungin—Injection site reaction—Capecitabine—esophageal cancer	0.00386	0.00504	CcSEcCtD
Micafungin—Hyponatraemia—Cisplatin—esophageal cancer	0.00384	0.00501	CcSEcCtD
Micafungin—Fungal infection—Methotrexate—esophageal cancer	0.00374	0.00489	CcSEcCtD
Micafungin—COMT—lymph node—esophageal cancer	0.00374	0.0474	CbGeAlD
Micafungin—Skin exfoliation—Capecitabine—esophageal cancer	0.00371	0.00484	CcSEcCtD
Micafungin—Fluid retention—Capecitabine—esophageal cancer	0.00369	0.00481	CcSEcCtD
Micafungin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00358	0.00468	CcSEcCtD
Micafungin—Hypokalaemia—Cisplatin—esophageal cancer	0.00348	0.00454	CcSEcCtD
Micafungin—Caspofungin—ABCB1—esophageal cancer	0.00348	1	CrCbGaD
Micafungin—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00344	0.00449	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.00342	0.0226	CbGpPWpGaD
Micafungin—Apnoea—Methotrexate—esophageal cancer	0.00341	0.00445	CcSEcCtD
Micafungin—Sepsis—Capecitabine—esophageal cancer	0.00337	0.0044	CcSEcCtD
Micafungin—Phlebitis—Capecitabine—esophageal cancer	0.00327	0.00427	CcSEcCtD
Micafungin—Thrombophlebitis—Capecitabine—esophageal cancer	0.00326	0.00425	CcSEcCtD
Micafungin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00324	0.00423	CcSEcCtD
Micafungin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00323	0.00421	CcSEcCtD
Micafungin—Bone disorder—Methotrexate—esophageal cancer	0.0032	0.00418	CcSEcCtD
Micafungin—COMT—Phase II conjugation—GSTT1—esophageal cancer	0.00319	0.0211	CbGpPWpGaD
Micafungin—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00318	0.00415	CcSEcCtD
Micafungin—COMT—Biological oxidations—ADH7—esophageal cancer	0.00318	0.021	CbGpPWpGaD
Micafungin—Pancytopenia—Cisplatin—esophageal cancer	0.00314	0.0041	CcSEcCtD
Micafungin—Oliguria—Methotrexate—esophageal cancer	0.00314	0.00409	CcSEcCtD
Micafungin—Hepatic failure—Capecitabine—esophageal cancer	0.00314	0.00409	CcSEcCtD
Micafungin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.00312	0.00408	CcSEcCtD
Micafungin—Renal failure acute—Capecitabine—esophageal cancer	0.00305	0.00399	CcSEcCtD
Micafungin—Inflammation—Methotrexate—esophageal cancer	0.00298	0.00389	CcSEcCtD
Micafungin—Atrial fibrillation—Capecitabine—esophageal cancer	0.00298	0.00388	CcSEcCtD
Micafungin—Renal impairment—Capecitabine—esophageal cancer	0.00296	0.00387	CcSEcCtD
Micafungin—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00291	0.00379	CcSEcCtD
Micafungin—Renal failure—Cisplatin—esophageal cancer	0.0029	0.00378	CcSEcCtD
Micafungin—Pulmonary embolism—Methotrexate—esophageal cancer	0.00289	0.00377	CcSEcCtD
Micafungin—Myocardial infarction—Cisplatin—esophageal cancer	0.00289	0.00377	CcSEcCtD
Micafungin—Hyponatraemia—Capecitabine—esophageal cancer	0.00283	0.00369	CcSEcCtD
Micafungin—COMT—Biological oxidations—ADH1B—esophageal cancer	0.00279	0.0184	CbGpPWpGaD
Micafungin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00279	0.00364	CcSEcCtD
Micafungin—Skin exfoliation—Methotrexate—esophageal cancer	0.00276	0.0036	CcSEcCtD
Micafungin—ARSA—Post-translational protein modification—CALR—esophageal cancer	0.00276	0.0182	CbGpPWpGaD
Micafungin—Bradycardia—Cisplatin—esophageal cancer	0.00269	0.00352	CcSEcCtD
Micafungin—Cardiac arrest—Capecitabine—esophageal cancer	0.00268	0.0035	CcSEcCtD
Micafungin—Blood creatinine increased—Capecitabine—esophageal cancer	0.00264	0.00345	CcSEcCtD
Micafungin—Urinary tract disorder—Cisplatin—esophageal cancer	0.00261	0.00341	CcSEcCtD
Micafungin—Liver function test abnormal—Capecitabine—esophageal cancer	0.0026	0.0034	CcSEcCtD
Micafungin—Connective tissue disorder—Cisplatin—esophageal cancer	0.0026	0.00339	CcSEcCtD
Micafungin—Urethral disorder—Cisplatin—esophageal cancer	0.00259	0.00338	CcSEcCtD
Micafungin—COMT—Biological oxidations—CYP26A1—esophageal cancer	0.00259	0.0171	CbGpPWpGaD
Micafungin—Abdominal pain upper—Capecitabine—esophageal cancer	0.00258	0.00336	CcSEcCtD
Micafungin—Hypokalaemia—Capecitabine—esophageal cancer	0.00257	0.00335	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00256	0.0169	CbGpPWpGaD
Micafungin—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00254	0.00331	CcSEcCtD
Micafungin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00254	0.00331	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—XBP1—esophageal cancer	0.00251	0.0166	CbGpPWpGaD
Micafungin—Sepsis—Methotrexate—esophageal cancer	0.00251	0.00327	CcSEcCtD
Micafungin—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00249	0.00325	CcSEcCtD
Micafungin—Flushing—Cisplatin—esophageal cancer	0.00246	0.0032	CcSEcCtD
Micafungin—Cardiac disorder—Cisplatin—esophageal cancer	0.00246	0.0032	CcSEcCtD
Micafungin—Abdominal distension—Capecitabine—esophageal cancer	0.00245	0.0032	CcSEcCtD
Micafungin—Thrombophlebitis—Methotrexate—esophageal cancer	0.00242	0.00316	CcSEcCtD
Micafungin—COMT—Biological oxidations—GSTO1—esophageal cancer	0.00241	0.0159	CbGpPWpGaD
Micafungin—ARSA—Metabolism of proteins—SLC30A7—esophageal cancer	0.00241	0.0159	CbGpPWpGaD
Micafungin—Immune system disorder—Cisplatin—esophageal cancer	0.00239	0.00312	CcSEcCtD
Micafungin—Mediastinal disorder—Cisplatin—esophageal cancer	0.00238	0.00311	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—GSTO1—esophageal cancer	0.00238	0.0157	CbGpPWpGaD
Micafungin—Arrhythmia—Cisplatin—esophageal cancer	0.00236	0.00308	CcSEcCtD
Micafungin—Hepatic failure—Methotrexate—esophageal cancer	0.00234	0.00305	CcSEcCtD
Micafungin—Pancytopenia—Capecitabine—esophageal cancer	0.00231	0.00302	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00231	0.0153	CbGpPWpGaD
Micafungin—Malnutrition—Cisplatin—esophageal cancer	0.0023	0.00301	CcSEcCtD
Micafungin—Erythema—Cisplatin—esophageal cancer	0.0023	0.00301	CcSEcCtD
Micafungin—Neutropenia—Capecitabine—esophageal cancer	0.00228	0.00297	CcSEcCtD
Micafungin—Renal failure acute—Methotrexate—esophageal cancer	0.00227	0.00297	CcSEcCtD
Micafungin—Hyperglycaemia—Capecitabine—esophageal cancer	0.0022	0.00287	CcSEcCtD
Micafungin—Pneumonia—Capecitabine—esophageal cancer	0.00219	0.00285	CcSEcCtD
Micafungin—Infestation—Capecitabine—esophageal cancer	0.00217	0.00284	CcSEcCtD
Micafungin—Infestation NOS—Capecitabine—esophageal cancer	0.00217	0.00284	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—ST6GAL1—esophageal cancer	0.00217	0.0143	CbGpPWpGaD
Micafungin—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00217	0.00283	CcSEcCtD
Micafungin—Tremor—Cisplatin—esophageal cancer	0.00216	0.00282	CcSEcCtD
Micafungin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.00215	0.00281	CcSEcCtD
Micafungin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00214	0.0028	CcSEcCtD
Micafungin—Renal failure—Capecitabine—esophageal cancer	0.00214	0.00279	CcSEcCtD
Micafungin—Myocardial infarction—Capecitabine—esophageal cancer	0.00213	0.00278	CcSEcCtD
Micafungin—Anaemia—Cisplatin—esophageal cancer	0.00213	0.00278	CcSEcCtD
Micafungin—Jaundice—Capecitabine—esophageal cancer	0.00212	0.00276	CcSEcCtD
Micafungin—Haematuria—Capecitabine—esophageal cancer	0.00207	0.0027	CcSEcCtD
Micafungin—Leukopenia—Cisplatin—esophageal cancer	0.00206	0.00269	CcSEcCtD
Micafungin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00205	0.00268	CcSEcCtD
Micafungin—Epistaxis—Capecitabine—esophageal cancer	0.00205	0.00267	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00202	0.0133	CbGpPWpGaD
Micafungin—Convulsion—Cisplatin—esophageal cancer	0.002	0.0026	CcSEcCtD
Micafungin—Bradycardia—Capecitabine—esophageal cancer	0.00199	0.00259	CcSEcCtD
Micafungin—COMT—Biological oxidations—ALDH2—esophageal cancer	0.00196	0.013	CbGpPWpGaD
Micafungin—Anxiety—Cisplatin—esophageal cancer	0.00195	0.00255	CcSEcCtD
Micafungin—Hepatitis—Capecitabine—esophageal cancer	0.00195	0.00255	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00195	0.00254	CcSEcCtD
Micafungin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00194	0.00253	CcSEcCtD
Micafungin—Urinary tract disorder—Capecitabine—esophageal cancer	0.00193	0.00251	CcSEcCtD
Micafungin—Oedema peripheral—Capecitabine—esophageal cancer	0.00192	0.00251	CcSEcCtD
Micafungin—Connective tissue disorder—Capecitabine—esophageal cancer	0.00192	0.0025	CcSEcCtD
Micafungin—Urethral disorder—Capecitabine—esophageal cancer	0.00191	0.0025	CcSEcCtD
Micafungin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00189	0.00247	CcSEcCtD
Micafungin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00188	0.00245	CcSEcCtD
Micafungin—COMT—Biological oxidations—GSTT1—esophageal cancer	0.00187	0.0123	CbGpPWpGaD
Micafungin—Infection—Cisplatin—esophageal cancer	0.00187	0.00244	CcSEcCtD
Micafungin—COMT—Transmission across Chemical Synapses—GNG7—esophageal cancer	0.00186	0.0123	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—CYP2A6—esophageal cancer	0.00185	0.0122	CbGpPWpGaD
Micafungin—Erythema multiforme—Capecitabine—esophageal cancer	0.00184	0.00241	CcSEcCtD
Micafungin—Nervous system disorder—Cisplatin—esophageal cancer	0.00184	0.00241	CcSEcCtD
Micafungin—Thrombocytopenia—Cisplatin—esophageal cancer	0.00184	0.0024	CcSEcCtD
Micafungin—Tachycardia—Cisplatin—esophageal cancer	0.00183	0.00239	CcSEcCtD
Micafungin—Skin disorder—Cisplatin—esophageal cancer	0.00183	0.00238	CcSEcCtD
Micafungin—Hyperhidrosis—Cisplatin—esophageal cancer	0.00182	0.00237	CcSEcCtD
Micafungin—Cardiac disorder—Capecitabine—esophageal cancer	0.00181	0.00236	CcSEcCtD
Micafungin—Flushing—Capecitabine—esophageal cancer	0.00181	0.00236	CcSEcCtD
Micafungin—Eosinophilia—Methotrexate—esophageal cancer	0.0018	0.00234	CcSEcCtD
Micafungin—Anorexia—Cisplatin—esophageal cancer	0.00179	0.00234	CcSEcCtD
Micafungin—ARSA—Metabolism—SLC52A3—esophageal cancer	0.00179	0.0118	CbGpPWpGaD
Micafungin—ARSA—Metabolism—BLVRB—esophageal cancer	0.00179	0.0118	CbGpPWpGaD
Micafungin—Angiopathy—Capecitabine—esophageal cancer	0.00177	0.00231	CcSEcCtD
Micafungin—Immune system disorder—Capecitabine—esophageal cancer	0.00176	0.0023	CcSEcCtD
Micafungin—Mediastinal disorder—Capecitabine—esophageal cancer	0.00176	0.00229	CcSEcCtD
Micafungin—Hypotension—Cisplatin—esophageal cancer	0.00176	0.00229	CcSEcCtD
Micafungin—COMT—Biological oxidations—PTGS1—esophageal cancer	0.00175	0.0116	CbGpPWpGaD
Micafungin—Chills—Capecitabine—esophageal cancer	0.00175	0.00228	CcSEcCtD
Micafungin—Arrhythmia—Capecitabine—esophageal cancer	0.00174	0.00227	CcSEcCtD
Micafungin—COMT—Transmission across Chemical Synapses—ALDH2—esophageal cancer	0.00174	0.0115	CbGpPWpGaD
Micafungin—Pancytopenia—Methotrexate—esophageal cancer	0.00172	0.00225	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00171	0.00224	CcSEcCtD
Micafungin—Mental disorder—Capecitabine—esophageal cancer	0.00171	0.00223	CcSEcCtD
Micafungin—Erythema—Capecitabine—esophageal cancer	0.0017	0.00222	CcSEcCtD
Micafungin—Malnutrition—Capecitabine—esophageal cancer	0.0017	0.00222	CcSEcCtD
Micafungin—Neutropenia—Methotrexate—esophageal cancer	0.0017	0.00221	CcSEcCtD
Micafungin—Dyspnoea—Cisplatin—esophageal cancer	0.00168	0.00219	CcSEcCtD
Micafungin—Dysgeusia—Capecitabine—esophageal cancer	0.00166	0.00217	CcSEcCtD
Micafungin—Back pain—Capecitabine—esophageal cancer	0.00164	0.00214	CcSEcCtD
Micafungin—Decreased appetite—Cisplatin—esophageal cancer	0.00163	0.00213	CcSEcCtD
Micafungin—Pneumonia—Methotrexate—esophageal cancer	0.00163	0.00212	CcSEcCtD
Micafungin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00162	0.00212	CcSEcCtD
Micafungin—Infestation NOS—Methotrexate—esophageal cancer	0.00162	0.00211	CcSEcCtD
Micafungin—Infestation—Methotrexate—esophageal cancer	0.00162	0.00211	CcSEcCtD
Micafungin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.0016	0.00209	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.0016	0.0106	CbGpPWpGaD
Micafungin—Tremor—Capecitabine—esophageal cancer	0.00159	0.00208	CcSEcCtD
Micafungin—Renal failure—Methotrexate—esophageal cancer	0.00159	0.00207	CcSEcCtD
Micafungin—Anaemia—Capecitabine—esophageal cancer	0.00157	0.00205	CcSEcCtD
Micafungin—Feeling abnormal—Cisplatin—esophageal cancer	0.00155	0.00202	CcSEcCtD
Micafungin—Haematuria—Methotrexate—esophageal cancer	0.00154	0.00201	CcSEcCtD
Micafungin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00153	0.002	CcSEcCtD
Micafungin—Epistaxis—Methotrexate—esophageal cancer	0.00153	0.00199	CcSEcCtD
Micafungin—ARSA—Metabolism—SLC10A2—esophageal cancer	0.00152	0.0101	CbGpPWpGaD
Micafungin—ARSA—Metabolism—CA1—esophageal cancer	0.00152	0.0101	CbGpPWpGaD
Micafungin—Leukopenia—Capecitabine—esophageal cancer	0.00152	0.00198	CcSEcCtD
Micafungin—Palpitations—Capecitabine—esophageal cancer	0.0015	0.00196	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—ACTB—esophageal cancer	0.00149	0.00987	CbGpPWpGaD
Micafungin—COMT—Biological oxidations—CYP1B1—esophageal cancer	0.00149	0.00984	CbGpPWpGaD
Micafungin—Body temperature increased—Cisplatin—esophageal cancer	0.00149	0.00194	CcSEcCtD
Micafungin—Cough—Capecitabine—esophageal cancer	0.00148	0.00193	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00147	0.0097	CbGpPWpGaD
Micafungin—Hypertension—Capecitabine—esophageal cancer	0.00147	0.00191	CcSEcCtD
Micafungin—Hepatitis—Methotrexate—esophageal cancer	0.00145	0.00189	CcSEcCtD
Micafungin—Arthralgia—Capecitabine—esophageal cancer	0.00145	0.00189	CcSEcCtD
Micafungin—Anxiety—Capecitabine—esophageal cancer	0.00144	0.00188	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00144	0.00187	CcSEcCtD
Micafungin—Urinary tract disorder—Methotrexate—esophageal cancer	0.00143	0.00187	CcSEcCtD
Micafungin—COMT—Neuronal System—GNG7—esophageal cancer	0.00142	0.00941	CbGpPWpGaD
Micafungin—Urethral disorder—Methotrexate—esophageal cancer	0.00142	0.00186	CcSEcCtD
Micafungin—COMT—Biological oxidations—CYP19A1—esophageal cancer	0.0014	0.00925	CbGpPWpGaD
Micafungin—Confusional state—Capecitabine—esophageal cancer	0.0014	0.00182	CcSEcCtD
Micafungin—ARSA—Metabolism—CA2—esophageal cancer	0.00139	0.0092	CbGpPWpGaD
Micafungin—Hypersensitivity—Cisplatin—esophageal cancer	0.00139	0.00181	CcSEcCtD
Micafungin—COMT—Metapathway biotransformation—CYP19A1—esophageal cancer	0.00138	0.00912	CbGpPWpGaD
Micafungin—Infection—Capecitabine—esophageal cancer	0.00138	0.0018	CcSEcCtD
Micafungin—Erythema multiforme—Methotrexate—esophageal cancer	0.00137	0.00179	CcSEcCtD
Micafungin—Shock—Capecitabine—esophageal cancer	0.00136	0.00178	CcSEcCtD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00136	0.00899	CbGpPWpGaD
Micafungin—Nervous system disorder—Capecitabine—esophageal cancer	0.00136	0.00177	CcSEcCtD
Micafungin—Thrombocytopenia—Capecitabine—esophageal cancer	0.00136	0.00177	CcSEcCtD
Micafungin—Tachycardia—Capecitabine—esophageal cancer	0.00135	0.00176	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—HSPA5—esophageal cancer	0.00135	0.00892	CbGpPWpGaD
Micafungin—Asthenia—Cisplatin—esophageal cancer	0.00135	0.00176	CcSEcCtD
Micafungin—Cardiac disorder—Methotrexate—esophageal cancer	0.00135	0.00176	CcSEcCtD
Micafungin—Skin disorder—Capecitabine—esophageal cancer	0.00135	0.00176	CcSEcCtD
Micafungin—Hyperhidrosis—Capecitabine—esophageal cancer	0.00134	0.00175	CcSEcCtD
Micafungin—COMT—Neuronal System—ALDH2—esophageal cancer	0.00133	0.00881	CbGpPWpGaD
Micafungin—Anorexia—Capecitabine—esophageal cancer	0.00132	0.00172	CcSEcCtD
Micafungin—Angiopathy—Methotrexate—esophageal cancer	0.00132	0.00172	CcSEcCtD
Micafungin—Immune system disorder—Methotrexate—esophageal cancer	0.00131	0.00171	CcSEcCtD
Micafungin—Mediastinal disorder—Methotrexate—esophageal cancer	0.00131	0.00171	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—CALR—esophageal cancer	0.00131	0.00864	CbGpPWpGaD
Micafungin—Chills—Methotrexate—esophageal cancer	0.0013	0.0017	CcSEcCtD
Micafungin—Hypotension—Capecitabine—esophageal cancer	0.00129	0.00169	CcSEcCtD
Micafungin—ARSA—Metabolism—PLCE1—esophageal cancer	0.00129	0.00855	CbGpPWpGaD
Micafungin—ARSA—Metabolism—ADH7—esophageal cancer	0.00129	0.00855	CbGpPWpGaD
Micafungin—Diarrhoea—Cisplatin—esophageal cancer	0.00129	0.00168	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—GHRL—esophageal cancer	0.00129	0.0085	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00128	0.00846	CbGpPWpGaD
Micafungin—Mental disorder—Methotrexate—esophageal cancer	0.00127	0.00166	CcSEcCtD
Micafungin—ARSA—Metabolism of proteins—FBXW7—esophageal cancer	0.00127	0.00836	CbGpPWpGaD
Micafungin—Erythema—Methotrexate—esophageal cancer	0.00126	0.00165	CcSEcCtD
Micafungin—Malnutrition—Methotrexate—esophageal cancer	0.00126	0.00165	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00126	0.00165	CcSEcCtD
Micafungin—Insomnia—Capecitabine—esophageal cancer	0.00125	0.00164	CcSEcCtD
Micafungin—Dysgeusia—Methotrexate—esophageal cancer	0.00124	0.00162	CcSEcCtD
Micafungin—Dyspnoea—Capecitabine—esophageal cancer	0.00124	0.00161	CcSEcCtD
Micafungin—Back pain—Methotrexate—esophageal cancer	0.00122	0.0016	CcSEcCtD
Micafungin—Dyspepsia—Capecitabine—esophageal cancer	0.00122	0.00159	CcSEcCtD
Micafungin—Decreased appetite—Capecitabine—esophageal cancer	0.0012	0.00157	CcSEcCtD
Micafungin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.0012	0.00156	CcSEcCtD
Micafungin—Vomiting—Cisplatin—esophageal cancer	0.0012	0.00156	CcSEcCtD
Micafungin—Fatigue—Capecitabine—esophageal cancer	0.00119	0.00156	CcSEcCtD
Micafungin—Rash—Cisplatin—esophageal cancer	0.00119	0.00155	CcSEcCtD
Micafungin—Constipation—Capecitabine—esophageal cancer	0.00118	0.00155	CcSEcCtD
Micafungin—Dermatitis—Cisplatin—esophageal cancer	0.00118	0.00155	CcSEcCtD
Micafungin—Anaemia—Methotrexate—esophageal cancer	0.00117	0.00152	CcSEcCtD
Micafungin—Feeling abnormal—Capecitabine—esophageal cancer	0.00114	0.00149	CcSEcCtD
Micafungin—ARSA—Metabolism—ADH1B—esophageal cancer	0.00114	0.0075	CbGpPWpGaD
Micafungin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00113	0.00148	CcSEcCtD
Micafungin—Leukopenia—Methotrexate—esophageal cancer	0.00113	0.00148	CcSEcCtD
Micafungin—Nausea—Cisplatin—esophageal cancer	0.00112	0.00146	CcSEcCtD
Micafungin—Cough—Methotrexate—esophageal cancer	0.0011	0.00144	CcSEcCtD
Micafungin—Urticaria—Capecitabine—esophageal cancer	0.0011	0.00144	CcSEcCtD
Micafungin—Body temperature increased—Capecitabine—esophageal cancer	0.0011	0.00143	CcSEcCtD
Micafungin—Abdominal pain—Capecitabine—esophageal cancer	0.0011	0.00143	CcSEcCtD
Micafungin—Convulsion—Methotrexate—esophageal cancer	0.0011	0.00143	CcSEcCtD
Micafungin—ARSA—Metabolism—TYMP—esophageal cancer	0.00109	0.00717	CbGpPWpGaD
Micafungin—Arthralgia—Methotrexate—esophageal cancer	0.00108	0.0014	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00107	0.00139	CcSEcCtD
Micafungin—ARSA—Metabolism—CYP26A1—esophageal cancer	0.00106	0.00697	CbGpPWpGaD
Micafungin—Confusional state—Methotrexate—esophageal cancer	0.00104	0.00136	CcSEcCtD
Micafungin—Anaphylactic shock—Methotrexate—esophageal cancer	0.00103	0.00135	CcSEcCtD
Micafungin—ARSA—Metabolism—ALOX15—esophageal cancer	0.00103	0.0068	CbGpPWpGaD
Micafungin—Infection—Methotrexate—esophageal cancer	0.00102	0.00134	CcSEcCtD
Micafungin—Hypersensitivity—Capecitabine—esophageal cancer	0.00102	0.00133	CcSEcCtD
Micafungin—Nervous system disorder—Methotrexate—esophageal cancer	0.00101	0.00132	CcSEcCtD
Micafungin—Thrombocytopenia—Methotrexate—esophageal cancer	0.00101	0.00132	CcSEcCtD
Micafungin—Skin disorder—Methotrexate—esophageal cancer	0.001	0.00131	CcSEcCtD
Micafungin—Hyperhidrosis—Methotrexate—esophageal cancer	0.000997	0.0013	CcSEcCtD
Micafungin—Asthenia—Capecitabine—esophageal cancer	0.000994	0.0013	CcSEcCtD
Micafungin—Anorexia—Methotrexate—esophageal cancer	0.000983	0.00128	CcSEcCtD
Micafungin—ARSA—Metabolism—TPI1—esophageal cancer	0.000981	0.00648	CbGpPWpGaD
Micafungin—ARSA—Metabolism—GSTO1—esophageal cancer	0.000981	0.00648	CbGpPWpGaD
Micafungin—Pruritus—Capecitabine—esophageal cancer	0.00098	0.00128	CcSEcCtD
Micafungin—Hypotension—Methotrexate—esophageal cancer	0.000964	0.00126	CcSEcCtD
Micafungin—Diarrhoea—Capecitabine—esophageal cancer	0.000948	0.00124	CcSEcCtD
Micafungin—ARSA—Metabolism—ALDOB—esophageal cancer	0.000941	0.00622	CbGpPWpGaD
Micafungin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00094	0.00123	CcSEcCtD
Micafungin—Insomnia—Methotrexate—esophageal cancer	0.000933	0.00122	CcSEcCtD
Micafungin—Dyspnoea—Methotrexate—esophageal cancer	0.00092	0.0012	CcSEcCtD
Micafungin—Somnolence—Methotrexate—esophageal cancer	0.000917	0.0012	CcSEcCtD
Micafungin—Dizziness—Capecitabine—esophageal cancer	0.000916	0.0012	CcSEcCtD
Micafungin—Dyspepsia—Methotrexate—esophageal cancer	0.000908	0.00119	CcSEcCtD
Micafungin—ARSA—Metabolism—GAPDH—esophageal cancer	0.000906	0.00598	CbGpPWpGaD
Micafungin—ARSA—Metabolism—CRABP1—esophageal cancer	0.000897	0.00593	CbGpPWpGaD
Micafungin—Decreased appetite—Methotrexate—esophageal cancer	0.000897	0.00117	CcSEcCtD
Micafungin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000891	0.00116	CcSEcCtD
Micafungin—Fatigue—Methotrexate—esophageal cancer	0.000889	0.00116	CcSEcCtD
Micafungin—Vomiting—Capecitabine—esophageal cancer	0.000881	0.00115	CcSEcCtD
Micafungin—Rash—Capecitabine—esophageal cancer	0.000874	0.00114	CcSEcCtD
Micafungin—Dermatitis—Capecitabine—esophageal cancer	0.000873	0.00114	CcSEcCtD
Micafungin—Headache—Capecitabine—esophageal cancer	0.000868	0.00113	CcSEcCtD
Micafungin—ARSA—Metabolism—GNG7—esophageal cancer	0.000854	0.00564	CbGpPWpGaD
Micafungin—Feeling abnormal—Methotrexate—esophageal cancer	0.00085	0.00111	CcSEcCtD
Micafungin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000844	0.0011	CcSEcCtD
Micafungin—Nausea—Capecitabine—esophageal cancer	0.000823	0.00107	CcSEcCtD
Micafungin—Urticaria—Methotrexate—esophageal cancer	0.000819	0.00107	CcSEcCtD
Micafungin—Abdominal pain—Methotrexate—esophageal cancer	0.000815	0.00106	CcSEcCtD
Micafungin—Body temperature increased—Methotrexate—esophageal cancer	0.000815	0.00106	CcSEcCtD
Micafungin—ARSA—Metabolism—ALDH2—esophageal cancer	0.0008	0.00529	CbGpPWpGaD
Micafungin—ARSA—Metabolism—GSTT1—esophageal cancer	0.000761	0.00503	CbGpPWpGaD
Micafungin—Hypersensitivity—Methotrexate—esophageal cancer	0.00076	0.000992	CcSEcCtD
Micafungin—ARSA—Metabolism—CYP2A6—esophageal cancer	0.000752	0.00497	CbGpPWpGaD
Micafungin—COMT—Metabolism—BLVRB—esophageal cancer	0.000752	0.00497	CbGpPWpGaD
Micafungin—COMT—Metabolism—SLC52A3—esophageal cancer	0.000752	0.00497	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000749	0.00495	CbGpPWpGaD
Micafungin—Asthenia—Methotrexate—esophageal cancer	0.00074	0.000966	CcSEcCtD
Micafungin—Pruritus—Methotrexate—esophageal cancer	0.00073	0.000952	CcSEcCtD
Micafungin—ARSA—Metabolism—PTGS1—esophageal cancer	0.000713	0.00471	CbGpPWpGaD
Micafungin—ARSA—Metabolism—ENO1—esophageal cancer	0.000713	0.00471	CbGpPWpGaD
Micafungin—Diarrhoea—Methotrexate—esophageal cancer	0.000706	0.000921	CcSEcCtD
Micafungin—ARSA—Metabolism—PSME1—esophageal cancer	0.000703	0.00464	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PSME2—esophageal cancer	0.000703	0.00464	CbGpPWpGaD
Micafungin—Dizziness—Methotrexate—esophageal cancer	0.000682	0.00089	CcSEcCtD
Micafungin—Vomiting—Methotrexate—esophageal cancer	0.000656	0.000856	CcSEcCtD
Micafungin—Rash—Methotrexate—esophageal cancer	0.00065	0.000849	CcSEcCtD
Micafungin—Dermatitis—Methotrexate—esophageal cancer	0.00065	0.000848	CcSEcCtD
Micafungin—Headache—Methotrexate—esophageal cancer	0.000646	0.000843	CcSEcCtD
Micafungin—COMT—Metabolism—CA1—esophageal cancer	0.000639	0.00423	CbGpPWpGaD
Micafungin—COMT—Metabolism—SLC10A2—esophageal cancer	0.000639	0.00423	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000614	0.00405	CbGpPWpGaD
Micafungin—Nausea—Methotrexate—esophageal cancer	0.000613	0.0008	CcSEcCtD
Micafungin—ARSA—Metabolism—CYP1B1—esophageal cancer	0.000606	0.00401	CbGpPWpGaD
Micafungin—COMT—Metabolism—CA2—esophageal cancer	0.000585	0.00386	CbGpPWpGaD
Micafungin—ARSA—Metabolism—CYP19A1—esophageal cancer	0.00057	0.00377	CbGpPWpGaD
Micafungin—COMT—Metabolism—PLCE1—esophageal cancer	0.000544	0.00359	CbGpPWpGaD
Micafungin—COMT—Metabolism—ADH7—esophageal cancer	0.000544	0.00359	CbGpPWpGaD
Micafungin—ARSA—Metabolism—HMOX1—esophageal cancer	0.00052	0.00344	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.00051	0.00337	CbGpPWpGaD
Micafungin—ARSA—Metabolism—ABCB1—esophageal cancer	0.000499	0.0033	CbGpPWpGaD
Micafungin—COMT—Metabolism—ADH1B—esophageal cancer	0.000477	0.00315	CbGpPWpGaD
Micafungin—COMT—Metabolism—TYMP—esophageal cancer	0.000456	0.00301	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP26A1—esophageal cancer	0.000443	0.00293	CbGpPWpGaD
Micafungin—COMT—Metabolism—ALOX15—esophageal cancer	0.000432	0.00285	CbGpPWpGaD
Micafungin—COMT—Metabolism—TPI1—esophageal cancer	0.000412	0.00272	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTO1—esophageal cancer	0.000412	0.00272	CbGpPWpGaD
Micafungin—COMT—Metabolism—ALDOB—esophageal cancer	0.000395	0.00261	CbGpPWpGaD
Micafungin—COMT—Metabolism—GAPDH—esophageal cancer	0.00038	0.00251	CbGpPWpGaD
Micafungin—ARSA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000377	0.00249	CbGpPWpGaD
Micafungin—COMT—Metabolism—CRABP1—esophageal cancer	0.000377	0.00249	CbGpPWpGaD
Micafungin—COMT—Metabolism—GNG7—esophageal cancer	0.000358	0.00237	CbGpPWpGaD
Micafungin—COMT—Metabolism—ALDH2—esophageal cancer	0.000336	0.00222	CbGpPWpGaD
Micafungin—ARSA—Metabolism—CREBBP—esophageal cancer	0.000334	0.0022	CbGpPWpGaD
Micafungin—COMT—Metabolism—GSTT1—esophageal cancer	0.00032	0.00211	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP2A6—esophageal cancer	0.000316	0.00209	CbGpPWpGaD
Micafungin—COMT—Metabolism—PTGS1—esophageal cancer	0.000299	0.00198	CbGpPWpGaD
Micafungin—COMT—Metabolism—ENO1—esophageal cancer	0.000299	0.00198	CbGpPWpGaD
Micafungin—ARSA—Metabolism—NOS3—esophageal cancer	0.000299	0.00197	CbGpPWpGaD
Micafungin—COMT—Metabolism—PSME2—esophageal cancer	0.000295	0.00195	CbGpPWpGaD
Micafungin—COMT—Metabolism—PSME1—esophageal cancer	0.000295	0.00195	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PTGS2—esophageal cancer	0.000273	0.00181	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP1B1—esophageal cancer	0.000255	0.00168	CbGpPWpGaD
Micafungin—COMT—Metabolism—CYP19A1—esophageal cancer	0.000239	0.00158	CbGpPWpGaD
Micafungin—ARSA—Metabolism—EP300—esophageal cancer	0.000227	0.0015	CbGpPWpGaD
Micafungin—COMT—Metabolism—HMOX1—esophageal cancer	0.000218	0.00144	CbGpPWpGaD
Micafungin—COMT—Metabolism—ABCB1—esophageal cancer	0.00021	0.00139	CbGpPWpGaD
Micafungin—ARSA—Metabolism—PIK3CA—esophageal cancer	0.000168	0.00111	CbGpPWpGaD
Micafungin—COMT—Metabolism—CREBBP—esophageal cancer	0.00014	0.000926	CbGpPWpGaD
Micafungin—COMT—Metabolism—NOS3—esophageal cancer	0.000125	0.000829	CbGpPWpGaD
Micafungin—COMT—Metabolism—PTGS2—esophageal cancer	0.000115	0.000758	CbGpPWpGaD
Micafungin—COMT—Metabolism—EP300—esophageal cancer	9.54e-05	0.00063	CbGpPWpGaD
Micafungin—COMT—Metabolism—PIK3CA—esophageal cancer	7.06e-05	0.000466	CbGpPWpGaD
